Exact match
Title 21
Title 21 / Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices / Section 355–1
Search
Search the current U.S. Code within Title 21
Search by citation or keyword across the current edition within Title 21.
20 results
355-1
Scoped to Title 21
Title 21
Title 21 / Section 355–2
21 U.S.C. § 355–2
Actions for delays of generic drugs and biosimilar biological products
Actions for delays of generic drugs and biosimilar biological products
Title 21
Title 21 / Section 355
Title 21
Title 21 / Section 353b
Title 21
Title 21 / Section 353d
21 U.S.C. § 353d
Process to update labeling for certain generic drugs
Process to update labeling for certain generic drugs
Title 21
Title 21 / Section 352
Title 21
Title 21 / Section 355a
Title 21
Title 21 / Section 829a
21 U.S.C. § 829a
Delivery of a controlled substance by a pharmacy to an administering practitioner
Delivery of a controlled substance by a pharmacy to an administering practitioner
Title 21
Title 21 / Section 331
Title 21
Title 21 / Section 333
Title 21
Title 21 / Section 301
Title 21
Title 21 / Section 360ff–1
Title 21
Title 21 / Section 355c–1
Title 21
Title 21 / Section 379g
Title 21
Title 21 / Section 360n
21 U.S.C. § 360n
Priority review to encourage treatments for tropical diseases
Priority review to encourage treatments for tropical diseases
Title 21
Title 21 / Section 360cc
21 U.S.C. § 360cc
Protection for drugs for rare diseases or conditions
Protection for drugs for rare diseases or conditions
Title 21
Title 21 / Section 360ff
21 U.S.C. § 360ff
Priority review to encourage treatments for rare pediatric diseases
Priority review to encourage treatments for rare pediatric diseases
Title 21
Title 21 / Section 355h
21 U.S.C. § 355h
Regulation of certain nonprescription drugs that are marketed without an approved drug application
Regulation of certain nonprescription drugs that are marketed without an approved drug application
Title 21
Title 21 / Section 356
21 U.S.C. § 356
Expedited approval of drugs for serious or life-threatening diseases or conditions
Expedited approval of drugs for serious or life-threatening diseases or conditions
Title 21
Title 21 / Section 360bbb–4a
21 U.S.C. § 360bbb–4a
Priority review to encourage treatments for agents that present national security threats
Priority review to encourage treatments for agents that present national security threats